Chronic Kidney Disease-Mineral and Bone Disorder

1Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan 2Centre for Nephrology & Urology, Department of Physiology, Shenzhen University Health Science Center, Shenzhen, China 3Centre for Nephrology, University College London, London, UK 4Centre for Cardiovascular Science, Queen’s Medical Research Institute, Edinburgh, UK


Guidelines for Authors Aims and Scope
Kidney Diseases aims to provide a platform for the communication of novel research findings from both clinical science and basic research and covers the entire spectrum of nephrological disorders. The journal has a particular interest in publishing research that supports communication and exchange of knowledge between East and West. The basic research section includes experimental work in animal models and in vitro. Clinical trials, observational studies, and other original clinical research work related to kidney diseases are the focus of the clinical science section; Moreover, important studies on hemodialysis and peritoneal dialysis are also considered. Invited review articles and editorials by renowned experts and high-quality rapid communications round off the contents of the journal.

Submission
Manuscripts written in English should be submitted online.
All manuscripts must be accompanied by a cover letter. Assurance should be given in the cover letter that the manuscript is not under simultaneous consideration by any other publication. In the cover letter, the authors should declare their potential conflicts of interest and provide a statement on authorship.
Should you experience any problems with your submission, please contact: All manuscripts must be accompanied by a cover letter. Assurance should be given in the cover letter that the manuscript is not under simultaneous consideration by any other publication. In the cover letter, the authors should declare their potential conflicts of interest and provide a statement on authorship.

Conditions
All manuscripts are subject to editorial review. Manuscripts are received with the explicit understanding that they are not under simultaneous consideration by any other publication. Submission of an article for publication implies transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of Kidney Diseases and may not be reproduced by any means, in whole or in part, without the written consent of the publisher. It is the author's responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.

Peer-Review Policy
Kidney Diseases is a peer-reviewed journal that uses a single blind peer-review. Our aim is to provide authors with fast and constructive feedback regarding their submitted manuscript. The Editor-in-Chief and the international Editorial Board ensure a thorough and fair peer-review and the highest scientific publishing standards. Submitted manuscripts are checked by the Editorial Office and forwarded to the Editor-in-Chief, who decides whether to accept/ reject or send the manuscript for review to at least two reviewers that can be members of the Editorial Board or external reviewers. Reviewers must have a recent publication record in the area of the submission, must not have published with the authors in the previous three years, and must not be from the same institution as the authors. The Editor-in-Chief makes a final decision on all papers submitted to the journal and is responsible to maintain high quality peer-review.

Conflicts of Interest
Authors are required to disclose any financial (funding, stocks, patents, employment, honoraria, royalties) or non-financial (political, personal, professional) interests/relationships that may be interpreted to have influenced the manuscript. Conflicts of Interest Statements will be published at the end of the manuscript. If there is no conflict of interest, please state The authors declare no conflicts of interest.

Ethics
Published research must comply with the guidelines for human studies and animal welfare regulations. Manuscripts reporting studies on human subjects should include evidence that the research was ethically conducted in accordance with the World Medical Association Declaration of Helsinki. In particular, authors must provide a "Statement of Ethics" at the end of the manuscript and declare that subjects (or their parents or guardians) have given their informed written consent and that the study protocol was approved by an appropriate ethics committee. If no approval was required, this must be stated in this section. All patients should be identified by numbers or aliases, not by their real names. For clinical trials, registration in a public trials registry at or before the time of first patient enrollment is a condition of consideration for publication. The trial registration number must be provided upon submission at the end of the abstract. Authors should also state that animal experimentation was approved by the appropriate institutional review body. Copies of these guidelines and policy statements must be available for review by the editors if necessary. Authors are encouraged to follow the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines for reporting on animal studies.

Plagiarism Policy
Whether intentional or not, plagiarism is a serious violation. We define plagiarism as a case in which a paper reproduces another work with at least 25% similarity and without citation. If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s).

Arrangement
The manuscript should conform to the following order: title page, abstract and key words, body, acknowledgments, references, figure legends, tables and figures. Manuscripts should be written in high-quality English suitable for effective communication to a professional medical audience. For authors whose native language is not English, use of a professional language editing service (http://www.karger.com/Resources/Authors) prior to submission can help to avoid delays with the review process. All pages, including the figure legends, should be numbered in sequence, and the first author's name should appear at the upper right corner of each page. Papers not conforming to the journal style will be returned without review.
Title page: The first page of each paper should indicate a concise title of no more than 150 characters, all authors' names (first name and surname), authors' institutional affiliations, and a short title for use as running head.
Corresponding author: The exact postal address of author(s) to whom correspondence, proofs, and reprint requests should be sent, including the postal code, must be given at the bottom of the title page. Please also supply phone number and e-mail address.
Abstract of Review Articles: Should be divided into the following subsections: Background, Summary and Key Messages. The Background should provide a brief clinical context for the review and is followed by the Summary, which should include a concise description of the main topics covered in the text. The Key Messages encapsulate the main conclusions of the review. Submit the abstract on a separate page. The abstract should be less than 300 words.
Key words: Following the abstract, an alphabetical list of five key words that reflect the content of the paper should be given. Reference Management Software: Use of EndNote is recommended for easy management and formatting of citations and reference lists.

Digital Object Identifier (DOI)
S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org.

Supplementary Material
Multimedia files and other supplementary files, directly relevant but not essential to the conclusions of a paper, enhance the online version of a publication and increase its visibility on the web. These files will undergo editorial review. The Editors reserve the right to limit the scope and length of the supplementary material. Multimedia and supplementary material should meet production quality standards for publication without the need for any modification or editing. Files should not exceed 10 Mb in size. Figures and tables need to have titles and legends, and all files should be supplied separately and labeled clearly. All supplementary material should be referred to in the main text. A DOI number will be assigned to supplementary material and it will be hosted online at https://karger.figshare.com under a CC BY license. Authors will be charged a processing fee of CHF 250.00 for supplementary material.

Self-Archiving/Green Open Access
Karger permits authors to archive their pre-prints (i.e. pre-peer review) or post-prints (i.e. accepted manuscript after peer review but before production) on their personal or their institution's internal website. In addition, authors may post their accepted manuscripts in public Open Access repositories and scientific networks (e.g. ResearchGate or Mendeley) no earlier than 12 months following publication of the final version of their article. For all self-archiving, the posted manuscripts must: • Be used for noncommercial purposes only It is the author's responsibility to fulfill these requirements.
For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article. Manuscripts to be archived in PubMed Central due to funding requirements will be submitted by Karger on the author's behalf [see Funding Organizations (NIH etc.)].
For self-archiving Author's Choice TM (Gold Open Access) articles, see Author's Choice TM .

Author's Choice TM
Karger's Author's Choice TM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.karger.com. The option is available for a onetime fee of CHF 3,000.00, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice. The final, published version of the article may be posted at any time and in any repository or on other websites, in accordance with the relevant Creative Commons license. Reposted Open Access articles must: It is the author's responsibility to fulfill these requirements.
For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.

Funding Organizations (NIH etc.)
The U.S. National Institutes of Health (NIH) Public Access Policy mandates that accepted, peer-reviewed manuscripts are archived in its digital database, PubMed Central (PMC), within 12 months of the official publication date. As a service to authors, Karger submits NIH-funded articles to PMC on behalf of the authors immediately upon publication. The NIH assigns a PMCID within approximately 1 month and the manuscript will appear in PMC after a 12-month embargo. For authors making their paper Open Access through Author's Choice TM , the embargo will be overridden, thereby accelerating the accessibility of the article. Karger also complies with other funders' requirements (including Wellcome Trust and RCUK) for submission to PMC. Authors should include information on their grants in the Acknowledgements section of their papers.

Proofs
Unless indicated otherwise, proofs are sent to the corresponding author and should be returned with the least possible delay. Alterations other than the correction of printer's errors are charged to the author.

Reprints
Order forms and a price list are sent with the proofs. Orders submitted after the issue is printed are subject to considerably higher prices.